August 28, 2007 - Scivanta Medical Corp. has entered into a development agreement with Sparton Medical Systems, in which Sparton will provide Scivanta engineering and development support for the hardware component of the Hickey Cardiac Monitoring System (HCMS).

August 28, 2007 – GE Healthcare announced that it has signed an agreement with Novation for GE’s advanced radiology and cardiology image and information management technologies, which will extend technology offerings to VHA Inc. (VHA) and the University HealthSystem Consortium (UHC), two national health care alliances, and Provista member healthcare organizations.

August 28, 2007 - CryoCor Inc., a medical device company focused on the treatment of cardiac arrhythmias, announced the completion of enrollment of its clinical study for the use of ablation for the treatment of atrial fibrillation.

CryoCor has enrolled over 170 patients in its clinical study and will complete a 12-month follow up for each patient. Completion of enrollment of atrial fibrillation ablation trials brings the company closer to bringing its product to market for treating atrial fibrillation.

August 28, 2007 — Niceware International LLC said ICCBBA Inc. granted licensing rights to enable Niceware Healthcare to provide ISBT 128-compliant blood bag labeling software solutions that support ISBT 128-compliant data structures and bar codes.
The licensed vendor status certifies that the NiceLabel software solutions provided by Niceware Healthcare meet the ISBT 128 global standard for the identification, labeling and information processing of human blood, tissue and organ products across international borders and disparate healthcare systems.

August 28, 2007 - Human embryonic stem cell (hESC)-derived cardiomyocytes improve heart function when transplanted after myocardial infarction, according to a study published in Nature Biotechnology.

August 28, 2007 – The FDA has granted ATS Medical Inc., a manufacturer and marketer of cardiac surgery products and services, approval to begin marketing additional sizes of its line of ATS Open Pivot Mechanical Heart Valves, as the company strives to expand its valve product offerings in the U.S. market.

The company’s applied to the FDA to add 25 and 35mm mitral valves to its line of U.S. products. Availability of these sizes is designed to allow ATS to gain additional implants in accounts that it already serves.

For more information: www.atsmedical.com

August 28, 2007 - LUMEDX Corp., a provider of integrated cardiovascular information systems, introduced cardiology software that automates donor/recipient record keeping for heart transplant centers, designed to help streamline and simplify the process of collecting and managing adult cardiac transplant patient data from first consultation through evaluation, activation, transplant and post-transplant follow-up visits.

August 28, 2007 – The FDA Advisory Panel will review the Premarket Approval (PMA) application for Endeavor Drug Eluting Coronary Stent by Medtronic Inc. in October, which would mark the introduction of a drug-eluting stent with a polymer-drug combination specifically designed to reduce restenosis to the market.

Medtronic’s PMA submission includes safety and efficacy data on more than 4,100 patients who have been treated with Endeavor in clinical trials that include follow up for as long as four years.

For more information: www.medtronic.com

August 27, 2007 – Toshiba America Medical Systems announced the installation of two Infinix CF-i/BP vascular X-ray systems at the Children’s Healthcare of Atlanta Sibley Heart Center, providing a five-axis bi-plane system that is designed for improved patient access.

The hospital selected the units for the five-axis bi-plane system, flat panel detector movement and C-arm flexibility, according to Robert Vincent, M.D., pediatric cardiologist and head of the Cardiac Catheterization Department, Children’s Sibley Heart Center.

August 24, 2007 - AGA Medical Corp. announced today that it has received FDA and European CE Mark approvals for the AMPLATZER Vascular Plug II ("vascular plug II"), is a self- expandable nitinol mesh occlusion device designed to be introduced in a minimally invasive fashion through a catheter.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now